{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:13:12Z","timestamp":1786122792260,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Today"],"DOI":"10.1007\/s00595-026-03463-1","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T12:29:05Z","timestamp":1786105745000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Redefining biologically borderline resectable pancreatic cancer: a data-driven reassessment of CA19-9 cutoff and a preoperative lymph node metastasis prediction model"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9912-9119","authenticated-orcid":false,"given":"Suguru","family":"Yamada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Nomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotaro","family":"Sanada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akimasa","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"3463_CR1","doi-asserted-by":"crossref","unstructured":"Brierley JD, GM, Wittekind C. UICC TNM Classification of Malignant Tumours, 8th Edition. Wiley Blackwell; 2016.","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"key":"3463_CR2","unstructured":"Network NCC. NCCN clinical practice guidelines in oncology (NCCN Guidelines\u00ae). Version 2 2025. NCCN; 2025."},{"issue":"4","key":"3463_CR3","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.surg.2017.04.023","volume":"162","author":"S Yamada","year":"2017","unstructured":"Yamada S, Fujii T, Takami H, Hayashi M, Iwata N, Kanda M, et al. Evaluation and proposal of novel resectability criteria for pancreatic cancer established by the Japan Pancreas Society. Surgery. 2017;162(4):784\u201391.","journal-title":"Surgery"},{"issue":"4","key":"3463_CR4","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00595-025-03163-2","volume":"56","author":"S Yamada","year":"2026","unstructured":"Yamada S, Oshima K, Nomoto K, Sanada S, Oshima Y, Ito M, et al. Prognostic discrepancies between surgery-first and neoadjuvant-treated resected pancreatic cancer in the same pathological stage. Surg Today. 2026;56(4):515\u201324.","journal-title":"Surg Today"},{"issue":"1","key":"3463_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.pan.2017.11.011","volume":"18","author":"S Isaji","year":"2018","unstructured":"Isaji S, Mizuno S, Windsor JA, Bassi C, Fernandez-Del Castillo C, Hackert T, et al. International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017. Pancreatology. 2018;18(1):2\u201311.","journal-title":"Pancreatology"},{"issue":"9","key":"3463_CR6","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.hpb.2019.01.012","volume":"21","author":"Y Kato","year":"2019","unstructured":"Kato Y, Yamada S, Tashiro M, Sonohara F, Takami H, Hayashi M, et al. Biological and conditional factors should be included when defining criteria for resectability for patients with pancreatic cancer. HPB (Oxford). 2019;21(9):1211\u20138.","journal-title":"HPB (Oxford)"},{"issue":"5","key":"3463_CR7","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.pan.2020.05.020","volume":"20","author":"H Takahashi","year":"2020","unstructured":"Takahashi H, Yamada D, Asukai K, Wada H, Hasegawa S, Hara H, et al. Clinical implications of the serum CA19-9 level in biological borderline resectability and biological downstaging in the setting of preoperative chemoradiation therapy for pancreatic cancer. Pancreatology. 2020;20(5):919\u201328.","journal-title":"Pancreatology"},{"issue":"6","key":"3463_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3892\/ol.2024.14412","volume":"27","author":"K Kobayashi","year":"2024","unstructured":"Kobayashi K, Einama T, Tsunenari T, Yonamine N, Takao M, Takihata Y, et al. Preoperative CA19\u20139 level and dual time point FDG\u2013PET\/CT as strong biological indicators of borderline resectability in pancreatic cancer: A retrospective study. Oncol Lett. 2024;27(6):279.","journal-title":"Oncol Lett"},{"issue":"8","key":"3463_CR9","doi-asserted-by":"publisher","first-page":"5411","DOI":"10.1245\/s10434-025-17407-5","volume":"32","author":"K Omiya","year":"2025","unstructured":"Omiya K, Oba A, Sugiura K, Maekawa A, Mie T, Kobayashi K, et al. Resectable Pancreatic Cancer with CA19-9\u2009>\u2009500 U\/mL: A Biological Indicator for Survival Benefit with Intensive Neoadjuvant Chemotherapy. Ann Surg Oncol. 2025;32(8):5411\u201320.","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"3463_CR10","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/jhbp.1049","volume":"29","author":"A Oba","year":"2022","unstructured":"Oba A, Del Chiaro M, Satoi S, Kim SW, Takahashi H, Yu J, et al. New criteria of resectability for pancreatic cancer: A position paper by the Japanese Society of Hepato-Biliary-Pancreatic Surgery (JSHBPS). J Hepatobiliary Pancreat Sci. 2022;29(7):725\u201331.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"2","key":"3463_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s13304-013-0205-4","volume":"65","author":"P Raj","year":"2013","unstructured":"Raj P, Kaman L, Singh R, Dahyia D, Bhattacharya A, Bal A. Sensitivity and specificity of FDG PET-CT scan in detecting lymph node metastasis in operable periampullary tumours in correlation with the final histopathology after curative surgery. Updates Surg. 2013;65(2):103\u20137.","journal-title":"Updates Surg"},{"issue":"1","key":"3463_CR12","doi-asserted-by":"publisher","first-page":"17296","DOI":"10.1038\/s41598-022-22126-y","volume":"12","author":"JK Yoon","year":"2022","unstructured":"Yoon JK, Park MS, Kim SS, Han K, Lee HS, Bang S, et al. Regional lymph node metastasis detected on preoperative CT and\/or FDG-PET may predict early recurrence of pancreatic adenocarcinoma after curative resection. Sci Rep. 2022;12(1):17296.","journal-title":"Sci Rep"},{"issue":"2","key":"3463_CR13","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.21037\/jgo-22-1034","volume":"14","author":"M Fiore","year":"2023","unstructured":"Fiore M, Coppola A, Petrianni GM, Trecca P, D\u2019Ercole G, Cimini P, et al. Advances in pre-treatment evaluation of pancreatic ductal adenocarcinoma: a narrative review. J Gastrointest Oncol. 2023;14(2):1114\u201330.","journal-title":"J Gastrointest Oncol"},{"issue":"5","key":"3463_CR14","first-page":"426","volume":"40","author":"A Nakao","year":"1993","unstructured":"Nakao A, Takagi H. Isolated pancreatectomy for pancreatic head carcinoma using catheter bypass of the portal vein. Hepatogastroenterology. 1993;40(5):426\u20139.","journal-title":"Hepatogastroenterology"},{"issue":"3","key":"3463_CR15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/jhbp.1092","volume":"29","author":"A Nakao","year":"2022","unstructured":"Nakao A. Isolated pancreatectomy using mesenteric approach. J Hepatobiliary Pancreat Sci. 2022;29(3):293\u2013300.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"3463_CR16","volume-title":"Classification of Pancretic Carcinoma. Fourth English Edition ed","author":"Japan Pancreas Society","year":"2017","unstructured":"Japan Pancreas Society. Classification of Pancretic Carcinoma. Fourth English Edition ed. Tokyo: Kanehara & Co., Ltd.; 2017."},{"issue":"18","key":"3463_CR17","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1200\/JCO.2005.05.3934","volume":"24","author":"CR Ferrone","year":"2006","unstructured":"Ferrone CR, Finkelstein DM, Thayer SP, Muzikansky A, Fernandez-delCastillo C, Warshaw AL. Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma. J Clin Oncol. 2006;24(18):2897\u2013902.","journal-title":"J Clin Oncol"},{"issue":"12","key":"3463_CR18","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1245\/s10434-008-0134-5","volume":"15","author":"SK Maithel","year":"2008","unstructured":"Maithel SK, Maloney S, Winston C, Gonen M, D\u2019Angelica MI, Dematteo RP, et al. Preoperative CA 19\u2009\u2013\u20099 and the yield of staging laparoscopy in patients with radiographically resectable pancreatic adenocarcinoma. Ann Surg Oncol. 2008;15(12):3512\u201320.","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"3463_CR19","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1245\/s10434-012-2809-1","volume":"20","author":"W Hartwig","year":"2013","unstructured":"Hartwig W, Strobel O, Hinz U, Fritz S, Hackert T, Roth C, et al. CA19-9 in potentially resectable pancreatic cancer: perspective to adjust surgical and perioperative therapy. Ann Surg Oncol. 2013;20(7):2188\u201396.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"3463_CR20","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/jhbp.845","volume":"29","author":"D Moon","year":"2022","unstructured":"Moon D, Kim H, Han Y, Byun Y, Choi Y, Kang J, et al. Preoperative carbohydrate antigen 19\u2009\u2013\u20099 and standard uptake value of positron emission tomography-computed tomography as prognostic markers in patients with pancreatic ductal adenocarcinoma. J Hepatobiliary Pancreat Sci. 2022;29(10):1133\u201341.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"4","key":"3463_CR21","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1097\/SLA.0000000000003049","volume":"271","author":"S Tsai","year":"2020","unstructured":"Tsai S, George B, Wittmann D, Ritch PS, Krepline AN, Aldakkak M, et al. Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer. Ann Surg. 2020;271(4):740\u20137.","journal-title":"Ann Surg"},{"issue":"3","key":"3463_CR22","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/SLA.0000000000005184","volume":"277","author":"TE Newhook","year":"2023","unstructured":"Newhook TE, Vreeland TJ, Griffin JF, Tidwell RSS, Prakash LR, Koay EJ, et al. Prognosis Associated With CA19-9 Response Dynamics and Normalization During Neoadjuvant Therapy in Resected Pancreatic Adenocarcinoma. Ann Surg. 2023;277(3):484\u201390.","journal-title":"Ann Surg"},{"issue":"1","key":"3463_CR23","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1245\/s10434-024-16361-y","volume":"32","author":"D Hashimoto","year":"2025","unstructured":"Hashimoto D, Satoi S, Yamaki S, Nakayama S, Shibata N, Matsumura K, et al. Neoadjuvant Treatment with Changes in Chemotherapy Regimens According to Carbohydrate Antigen 19\u2009\u2013\u20099 Level for Resectable\/Borderline Resectable Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol. 2025;32(1):517\u201328.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"3463_CR24","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/bjs.1800820340","volume":"82","author":"A Nakao","year":"1995","unstructured":"Nakao A, Harada A, Nonami T, Kaneko T, Murakami H, Inoue S, et al. Lymph node metastases in carcinoma of the head of the pancreas region. Br J Surg. 1995;82(3):399\u2013402.","journal-title":"Br J Surg"},{"issue":"8","key":"3463_CR25","first-page":"1090","volume":"84","author":"A Nakao","year":"1997","unstructured":"Nakao A, Harada A, Nonami T, Kaneko T, Nomoto S, Koyama H, et al. Lymph node metastasis in carcinoma of the body and tail of the pancreas. Br J Surg. 1997;84(8):1090\u20132.","journal-title":"Br J Surg"},{"issue":"9","key":"3463_CR26","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/jhbp.12179","volume":"32","author":"S Yamada","year":"2025","unstructured":"Yamada S, Fujii T, Oshima K, Nomoto K, Oshima Y, Hayashi M, et al. Clinical Impact for Prognostic Index of Nodal Stations and Reconsideration of Optimal Regional Lymph Node Station in Pancreatic Cancer. J Hepatobiliary Pancreat Sci. 2025;32(9):667\u201378.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"11","key":"3463_CR27","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/s41419-021-04258-7","volume":"12","author":"CH Chang","year":"2021","unstructured":"Chang CH, Pauklin S. Extracellular vesicles in pancreatic cancer progression and therapies. Cell Death Dis. 2021;12(11):973.","journal-title":"Cell Death Dis"},{"issue":"6","key":"3463_CR28","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1097\/SLA.0000000000006209","volume":"281","author":"D Shah","year":"2025","unstructured":"Shah D, Wells A, Cox M, Dawravoo K, Abad J, D\u2019Souza A, et al. Prospective Evaluation of Circulating Tumor DNA Using Next-generation Sequencing as a Biomarker During Neoadjuvant Chemotherapy in Localized Pancreatic Cancer. Ann Surg. 2025;281(6):997\u20131005.","journal-title":"Ann Surg"},{"issue":"1","key":"3463_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/SLA.0000000000006730","volume":"283","author":"M Unno","year":"2026","unstructured":"Unno M, Motoi F, Matsuyama Y, Satoi S, Toyama H, Matsumoto I, et al. Neoadjuvant Chemotherapy With Gemcitabine and S-1 Versus Upfront Surgery for Resectable Pancreatic Cancer: Results of the Randomized Phase II\/III Prep-02\/JSAP05 Trial. Ann Surg. 2026;283(1):57\u201364.","journal-title":"Ann Surg"},{"issue":"4","key":"3463_CR30","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.pan.2024.03.012","volume":"24","author":"S Yamada","year":"2024","unstructured":"Yamada S, Hashimoto D, Yamamoto T, Yamaki S, Oshima K, Murotani K, et al. Reconsideration of the clinical impact of neoadjuvant therapy in resectable and borderline resectable pancreatic cancer: A dual-institution collaborative clinical study. Pancreatology. 2024;24(4):592\u20139.","journal-title":"Pancreatology"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-026-03463-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00595-026-03463-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-026-03463-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T12:29:07Z","timestamp":1786105747000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00595-026-03463-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":30,"alternative-id":["3463"],"URL":"https:\/\/doi.org\/10.1007\/s00595-026-03463-1","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"17 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no commercial affiliations that could pose conflicts of interest in connection with this study. This research did not receive any specific grants from funding agencies in the public, commercial, or not-for-profit sectors.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}